Skip to main content

ReSTORE - A phase 3 study of the efficacy and safety of rezafungin for injection versus intravenous caspofungin followed by optional oral fluconazole step-down in the treatment of subjects with candidemia and/or invasive candidiasis

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Infectious Diseases

Awarded By

Cidara Therapeutics, Inc.

Start Date

January 23, 2019

End Date

March 7, 2022
 

Administered By

Medicine, Infectious Diseases

Awarded By

Cidara Therapeutics, Inc.

Start Date

January 23, 2019

End Date

March 7, 2022